Inactive Instrument

CHF Solutions Inc Stock Nasdaq

Equities

US12542Q5080

Advanced Medical Equipment & Technology

Sales 2024 * 10.41M Sales 2025 * 12.9M Capitalization 1.71M
Net income 2024 * -17M Net income 2025 * -14M EV / Sales 2024 * 0.16 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.13 x
P/E ratio 2024 *
-0.11 x
P/E ratio 2025 *
-0.2 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.94%
More Fundamentals * Assessed data
Dynamic Chart
Nuwellis, Inc. Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health CI
Nuwellis, Inc. Announces Results from Two New Clinical Data Analyses from the AVOID-HF Trial, Which Demonstrate the Benefits of its Aquadex System in Reducing Heart Failure Readmissions at 30 Days CI
Nuwellis, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Transcript : Nuwellis, Inc., Q4 2023 Earnings Call, Mar 05, 2024
Earnings Flash (NUWE) NUWELLIS Reports Q4 Revenue $2.6M MT
Certain Warrants of Nuwellis, Inc. are subject to a Lock-Up Agreement Ending on 16-JAN-2024. CI
Certain Stock Options of Nuwellis, Inc. are subject to a Lock-Up Agreement Ending on 16-JAN-2024. CI
Certain Common Stock of Nuwellis, Inc. are subject to a Lock-Up Agreement Ending on 16-JAN-2024. CI
Nuwellis Receives FDA Approval for Specialized Catheter MT
Nuwellis, Inc. Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter CI
Nuwellis, Inc. Announces New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring Foriatric Patients CI
Ladenburg Thalmann Downgrades Nuwellis to Neutral From Buy MT
Nuwellis, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Nuwellis, Inc., Q3 2023 Earnings Call, Nov 07, 2023
Earnings Flash (NUWE) NUWELLIS Reports Q3 Revenue $2.4M MT
More news
Managers TitleAgeSince
Chief Executive Officer 66 19-05-06
Director of Finance/CFO 44 12-12-31
Chairman 75 12-08-31
Members of the board TitleAgeSince
Chairman 75 12-08-31
Director/Board Member 61 Oct. 31
Director/Board Member 74 11-08-02
More insiders
Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
More about the company